ATE416182T1 - Kristalline form von risedronat-mononatrium - Google Patents

Kristalline form von risedronat-mononatrium

Info

Publication number
ATE416182T1
ATE416182T1 AT05700509T AT05700509T ATE416182T1 AT E416182 T1 ATE416182 T1 AT E416182T1 AT 05700509 T AT05700509 T AT 05700509T AT 05700509 T AT05700509 T AT 05700509T AT E416182 T1 ATE416182 T1 AT E416182T1
Authority
AT
Austria
Prior art keywords
mononatrium
risedronate
crystalline form
hydroxyethylidene
pyridyl
Prior art date
Application number
AT05700509T
Other languages
English (en)
Inventor
Jindrich Richter
Josef Jirman
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE416182T1 publication Critical patent/ATE416182T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Cephalosporin Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Pyridine Compounds (AREA)
AT05700509T 2004-02-05 2005-02-04 Kristalline form von risedronat-mononatrium ATE416182T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20040199A CZ298639B6 (cs) 2004-02-05 2004-02-05 Krystalická forma risedronátu monosodného

Publications (1)

Publication Number Publication Date
ATE416182T1 true ATE416182T1 (de) 2008-12-15

Family

ID=34832121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05700509T ATE416182T1 (de) 2004-02-05 2005-02-04 Kristalline form von risedronat-mononatrium

Country Status (8)

Country Link
EP (1) EP1711507B1 (de)
AT (1) ATE416182T1 (de)
CZ (1) CZ298639B6 (de)
DE (1) DE602005011401D1 (de)
EA (1) EA008494B1 (de)
PL (2) PL380526A1 (de)
UA (1) UA85218C2 (de)
WO (1) WO2005075487A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005003557D1 (de) 2004-02-26 2008-01-10 Zentiva As Amorphe formen von of risedronat-mononatrium
WO2007042048A2 (en) * 2005-10-11 2007-04-19 Sandoz A/S Method for preparing crystalline sodium risedronate
KR20090005206A (ko) 2006-05-11 2009-01-12 인드-스위프트 래버러토리즈 리미티드 순수한 리세드론산 또는 염의 제조 방법
DE102007030370A1 (de) 2007-06-29 2009-01-02 Ratiopharm Gmbh Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728805B1 (fr) * 1994-12-29 1997-03-28 Total Raffinage Distribution Procede et dispositif pour le strippage de solides fluidises et utilisation dans un procede de craquage a l'etat fluide
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
US20030195170A1 (en) * 2002-04-11 2003-10-16 Judith Aronhime Novel polymorphs and pseudopolymorphs of risedronate sodium

Also Published As

Publication number Publication date
CZ298639B6 (cs) 2007-12-05
EP1711507B1 (de) 2008-12-03
PL1711507T3 (pl) 2009-06-30
DE602005011401D1 (de) 2009-01-15
UA85218C2 (en) 2009-01-12
EP1711507A1 (de) 2006-10-18
WO2005075487A1 (en) 2005-08-18
EA008494B1 (ru) 2007-06-29
EA200601366A1 (ru) 2006-12-29
PL380526A1 (pl) 2007-02-19
CZ2004199A3 (cs) 2005-09-14

Similar Documents

Publication Publication Date Title
RS53599B1 (en) PIRIDON DERIVATIVES FOR STRESS MODULATION OF ACTIVATED PROTEIN KINASE SYSTEMS
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
RS52274B (en) UNIT DIARYLHIDANTOIN
RS52931B (en) VIRAL POLYMERASE INHIBITORS
BRPI0514372A (pt) inibidores de tiazol de frutose 1, 6-bisfosfatase
ATE516291T1 (de) Thenopyrimidin-verbindungen mit fungizider aktivität
EA200802213A1 (ru) Способы лечения заболеваний крови
NO20081003L (no) 2-Aminopyrimidinderivater som modulatorer av histamin-H4-reseptoraktivitet
BR0313330A (pt) Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
EA201000563A1 (ru) Триазолпиридиновые ингибиторы 11-бета- гидроксистероид - дегидрогеназы типа i
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
ATE458731T1 (de) Pyrimidin-derivate zur behandlung von anormalem zellwachstum
RS52784B (en) They're TANATE RAZAGILINA
RS52843B (en) THE NEW IS THE HYDROGEN SULPHATE
ATE478082T1 (de) Phosphonate, monophosphonamidate, bisphosphonamidate zur behandlung von virenerkrankungen
CO6382079A2 (es) Composiciones insecticidas estables a base de sulfoximina
BRPI0414598A (pt) indóis substituìdos
GT200600174A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
DK1663989T3 (da) Krystallisk form af bis(E)-7-[4(4-fluorphenyl)-6-isopropyl-2-methyl(methylsulfonyl)aminopyrimidin-5-yl(3R,5S))-3-5-dihydroxyhept-6-ensyrecalciumsalt
EA200600197A1 (ru) Получение производных соединения 1,3-дифенилпроп-2-ен-1-он
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
EA200601438A1 (ru) Аморфные формы мононатриевой соли ризедроновой кислоты
ATE416182T1 (de) Kristalline form von risedronat-mononatrium
CY1109496T1 (el) Τρυγικο και φωσφορικο αλας της 3,4-διαμινοπυριδινης, φαρμακευτικες συνθεσεις και χρησεις αυτων
ATE366045T1 (de) Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties